David Liposarcoma Research Initiative News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David liposarcoma research initiative. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Liposarcoma Research Initiative Today - Breaking & Trending Today

Dana-Farber Cancer Institute Establishes David Liposarcoma Research Initiative


Date Time
Dana-Farber Cancer Institute Establishes David Liposarcoma Research Initiative
Dana-Farber Cancer Institute announced that The Rossy Foundation has committed $10 million to establish the David Liposarcoma Research Initiative. The five-year initiative will spearhead groundbreaking research into liposarcoma at Dana-Farber and external collaborating partner institutions, with the aim of transforming the treatment of this rare, underfunded, and understudied disease in order to improve care of patients through research.
This commitment from The Rossy Foundation will focus on collaborative research among various departments at Dana-Farber-including liposarcoma biology, biochemistry, immunology, metabolism, genomics, and epigenetics. By conducting research to improve fundamental understanding of the molecular mechanisms of this disease, the initiative may lead to new approaches to overcome treatment resistance, as well as new strategies for clinical research to impr ....

United States , Dana Farber Cancer Institute , Gregoryj David , Laurieh Glimcher , Broad Institute , David Liposarcoma Research Initiative , Sarcoma Center At Dana Farber , Rossy Foundation , Blood Disorders Center , Sarcoma Center , Cancer Center , Harvard Medical School , Dana Farber Sarcoma Center , David Liposarcoma Research Initiative International Scientific Symposium , Dana Farber Brigham Cancer Center , Rossy Cancer Network , Dana Farber Campaign , David Liposarcoma Research , George Demetri , Experimental Therapeutics , Quick Family Chair , Medical Oncology , Scientific Advisory , Farber Cancer Institute , Comprehensive Cancer Center , Harvard Medical ,